Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ketamine for Postoperative Sore Throat Relief
NCT07746115Completed
- Sponsor
- Aswan University Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in postoperative sore throat (POST) (3 arms), sponsored by Aswan University Hospital. Primary endpoint: Incidence of Postoperative Sore Throat at 2 hours. Started Aug 2026; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT07746115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746115.